2-(5-(Difluoromethoxy)-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

1-Octen-3-one (stabilized with BHT)>95.0%(GC)5g

C8-Alcyne-dU-CEP, ≥95%, 250 mg, emballage plastique.

(E)-2-(2,6-Dichlorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 1g

TERT-BUTYL (3-OXOCYCLOPENTYL)METHYLCARBAMATE, 95.0%, 100mg

p-Cymene>95.0%(GC)500mL

5-Chloro-6-(4-chlorophenyl)-2-methylpyridazin-3(2H)-one, 95.0%, 1g

3-((2,5-Difluorophenyl)thio)butan-2-one, 95%, 250mg

HMBA Linker, 98%, 100g

tert-Butyl 5-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-1-carboxylate, 98%, 250mg

6-Fluoro-3,4-dihydro-1(2H)-isoquinolinone, 95.0%, 5g

trans-4-(tert-Butyldiphenylsilyloxy)-L-proline>98.0%(HPLC)(T)1g

4-Aminobenzylamine>98.0%(GC)(T)250g